Interference of O.C.T. embedding compound with hormone receptor assays.
Muensch H, Maslow WC
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to determine if OCT embedding compound can interfere with the receptor binding assays for ER and PR. ER and PR binding was quantified by the dextran charcoal method. Breast tumor specimens were divided and embedded in OCT or left untreated before being snap-frozen in liquid nitrogen and stored at -70 degrees C until analysis.
Summary of Findings
Although statistical significance was not assessed and between patient variability was high, estrogen receptor (ER) and progesterone receptor (PR) binding were reduced in all 22 breast tumor biopsies embedded in OCT prior to snap-freezing compared to un-embedded case-matched controls. The magnitude of difference in mean Bmax values was greater for PR (OCT-embedded=10.6 fmol/mg , un-embedded control=109.6 fmol/mg) than ER (OCT-embedded=141.2 fmol/mg, un-embedded control=173.5 fmol/mg). OCT compound also induced an artifactual increase in color formation during the Lowry protein assay, as albumin standards that contained 4% OCT had a 20-25% higher absorption than those that did not.
Biospecimens
TissueBreastPreservation Types
OCTFrozenDiagnoses
NeoplasticCarcinomaPlatforms
ProteinReceptor bindingPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Preservation Type of fixation/preservation OCTSnap frozenReceptor binding Specific Targeted peptide/protein ERPR